Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Viscum Mali 1
Generic Name
Viscum Mali 1
Active Ingredient
Viscum Album Fruiting TopCategory
Standardized Chemical Allergen [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 3 [hp_X]/mL | LIQUID | ORAL | 48951-9308 |
Detailed information about Viscum Mali 1
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Viscum Mali 1, you must consult a qualified healthcare professional.
Viscum Album Fruiting Top is a standardized chemical allergen and plant extract used in immunotherapeutic applications and adjunctive clinical settings. It belongs to the class of non-standardized plant allergenic extracts and is often evaluated for its immunomodulatory properties.
Dosage for Viscum Album Fruiting Top is highly individualized and must be managed by a healthcare professional experienced in allergenic extracts or mistletoe therapy.
The safety and efficacy of Viscum Album Fruiting Top in pediatric populations have not been extensively established in large-scale clinical trials.
No specific dosage adjustments are provided in the standard labeling for patients with renal impairment, as the systemic load of the extract is typically low. However, caution is advised in patients with end-stage renal disease due to potential changes in protein metabolite clearance.
Because Viscum Album is not primarily metabolized by the liver's CYP450 system, hepatic impairment is not considered a primary contraindication. Nevertheless, patients with severe liver disease should be monitored for systemic inflammatory responses.
Geriatric patients may have a more sensitive immune system or reduced physiological reserve. Clinical guidance suggests starting at the lowest possible dose and monitoring closely for cardiovascular changes, especially given the extract's potential adrenergic activity.
If you miss a dose of Viscum Album Fruiting Top, contact your healthcare provider immediately. In immunotherapy, missing a dose may require a reduction in the next dose to prevent an exaggerated immune response. Do not double the dose to catch up.
An overdose of Viscum Album Fruiting Top can lead to a severe systemic immune reaction. Signs of overdose include:
In case of suspected overdose, seek emergency medical attention immediately. Treatment is symptomatic and may include antihistamines, corticosteroids, or epinephrine in cases of anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions precisely. Do not adjust your dose or administration frequency without direct medical guidance from your specialist.
Most patients undergoing therapy with Viscum Album Fruiting Top will experience some form of localized reaction. These are often considered a sign that the immune system is responding to the treatment.
> Warning: Stop taking Viscum Album Fruiting Top and call your doctor or emergency services immediately if you experience any of the following:
With prolonged use, some patients may develop chronic induration (hardening) of the skin at frequent injection sites. There is also a theoretical risk of developing autoantibodies if the immune system is excessively stimulated over many years, although this is rarely documented in clinical literature. Regular monitoring of immune markers is recommended for long-term users.
No FDA black box warnings are currently issued specifically for "Viscum Album Fruiting Top" as an isolated ingredient. However, as an Allergenic Extract, it carries the standard class warning regarding the risk of severe systemic allergic reactions and the necessity for administration in a setting equipped with emergency resuscitation equipment (e.g., epinephrine).
Report any unusual symptoms or persistent side effects to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.
Viscum Album Fruiting Top is a potent biological extract that significantly alters immune function. It should only be used under the strict guidance of a physician trained in immunology or specialized botanical medicine. Before starting therapy, patients must undergo a thorough evaluation of their current immune status and any history of hypersensitivity.
No FDA black box warnings for Viscum Album Fruiting Top. However, healthcare providers must be aware that all injectable allergenic extracts carry an inherent risk of anaphylaxis. Patients should be observed for at least 30 minutes following each injection.
Patients on long-term Viscum Album therapy should undergo regular laboratory monitoring, including:
Viscum Album may cause temporary fatigue or dizziness shortly after administration. Patients should avoid driving or operating heavy machinery for at least several hours after an injection until they know how the medication affects them.
Alcohol may increase the risk of vasodilation and exacerbate the potential for orthostatic hypotension or flushing associated with Viscum Album. It is recommended to avoid alcohol consumption on the day of treatment.
Do not stop Viscum Album therapy abruptly without consulting your doctor, especially if being used for desensitization. Abrupt discontinuation can lead to a loss of the acquired immune tolerance, increasing the risk of a severe reaction if the therapy is restarted later.
> Important: Discuss all your medical conditions, including any history of heart disease, thyroid issues, or autoimmune disorders, with your healthcare provider before starting Viscum Album Fruiting Top.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, as the complex profile of Viscum Album Fruiting Top can interact with many different classes of drugs.
Viscum Album Fruiting Top must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients who are allergic to other members of the Santalales order or specific tree pollens may exhibit cross-sensitivity to Viscum Album. A thorough allergy profile should be established prior to the first dose.
> Important: Your healthcare provider will evaluate your complete medical history, including any dormant infections or cardiovascular issues, before prescribing Viscum Album Fruiting Top.
Viscum Album Fruiting Top is generally classified as Category C (or equivalent in newer systems). There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have shown that high doses of mistletoe lectins may have embryotoxic effects. Furthermore, the risk of a systemic allergic reaction (anaphylaxis) during pregnancy poses a significant threat to fetal oxygenation. Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. It is typically avoided during the first trimester.
It is unknown whether the lectins or viscotoxins from Viscum Album are excreted in human milk. Because many proteins are degraded in the infant's digestive tract, the risk may be low, but the potential for sensitizing the infant to mistletoe allergens exists. Caution should be exercised when Viscum Album is administered to a nursing woman. Decisions should be based on the importance of the drug to the mother.
Viscum Album is not FDA-approved for general use in children under the age of 12 for most indications. In pediatric allergy cases, it must be used with extreme caution due to the higher risk of rapid-onset anaphylaxis in children. Growth parameters should be monitored if used long-term, although there is no current evidence suggesting an impact on the growth hormone axis.
Clinical studies of Viscum Album have not included sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, elderly patients are more likely to have underlying cardiovascular disease or reduced renal function. The Adrenergic Agonist and Nitrate Vasodilator properties of the extract may pose a higher risk of arrhythmias or falls due to hypotension in this population. Dosing should be conservative.
Specific guidelines for GFR-based adjustments are not available. However, since the breakdown products are excreted renally, patients with a GFR < 30 mL/min should be monitored for signs of systemic toxicity or prolonged fever after administration. Dialysis is unlikely to clear the large protein molecules (lectins) effectively.
In patients with hepatic impairment (Child-Pugh Class B or C), there is a theoretical risk of altered protein synthesis and immune regulation. While no specific dose reduction is mandated, these patients should be monitored for unusual inflammatory responses or changes in coagulation factors.
> Important: Special populations require individualized medical assessment and often require a slower dose escalation schedule.
Viscum Album Fruiting Top acts as a complex biological response modifier. Its primary activity is driven by Mistletoe Lectins (ML I, II, III), which are type II ribosome-inactivating proteins. These lectins consist of an A-chain (which inhibits protein synthesis by removing an adenine residue from ribosomal RNA) and a B-chain (which binds to cell surface carbohydrates).
Additionally, the extract contains Viscotoxins, which are thionins that exert rapid cytolytic effects by creating pores in cell membranes. The pharmacological profile also includes interaction with alpha- and beta-adrenergic receptors, likely mediated by low-molecular-weight phenolics or alkaloids, and Nitrate-like activity that promotes the release of nitric oxide from vascular endothelium.
The dose-response relationship of Viscum Album is often non-linear (hormetic). Low doses typically stimulate immune cell proliferation and cytokine release, while very high doses may be immunosuppressive or cytotoxic.
| Parameter | Value |
|---|---|
| Bioavailability | <5% (Oral); ~80% (Subcutaneous) |
| Protein Binding | High (to cell surface glycoproteins) |
| Half-life | 2 - 12 hours (Lectin components) |
| Tmax | 1 - 4 hours (Subcutaneous) |
| Metabolism | Proteolytic degradation (Non-CYP) |
| Excretion | Renal (Metabolites) |
Viscum Album is classified as a Standardized Chemical Allergen [EPC]. It is related to other allergenic extracts like Ambrosia artemisiifolia (Ragweed) or Betula verrucosa (Birch), but is unique in its specific cytotoxic and adrenergic properties.
Common questions about Viscum Mali 1
Viscum Album Fruiting Top is primarily used as a standardized allergenic extract for the diagnosis and treatment of hypersensitivity to mistletoe proteins. In various clinical settings, particularly in Europe, it is also utilized as an adjunctive immunotherapeutic agent to support the immune system during chronic illnesses. It works by stimulating the activity of white blood cells, such as natural killer cells and T-lymphocytes. Some healthcare providers also use it in highly diluted homeopathic forms for conditions like hypertension. However, its use should always be directed by a specialist due to its complex pharmacological effects. Always consult your doctor to see if this specific extract is appropriate for your clinical needs.
The most frequent side effects are localized reactions at the site of injection, including redness, itching, and mild swelling. Many patients also experience a slight increase in body temperature or a mild fever, which is often interpreted by clinicians as a sign that the immune system is responding to the treatment. Flu-like symptoms, such as fatigue, headache, and muscle aches, may also occur shortly after administration. These effects are usually temporary and resolve within 24 to 48 hours. If you experience a high fever or a very large skin reaction, you should contact your healthcare provider immediately. It is important to monitor these reactions closely during the initial phases of therapy.
It is generally advised to avoid or significantly limit alcohol consumption on the days you receive a Viscum Album injection. Alcohol can cause blood vessels to dilate, which may worsen the redness or swelling at the injection site. Furthermore, alcohol can increase the risk of dizziness or a drop in blood pressure, which are potential side effects of the extract's nitrate-like and adrenergic components. Drinking alcohol may also mask the body's natural response to the medication, making it harder for your doctor to determine the correct dose. For the best results and safety, maintain a clear system during the active window of the drug's effect. Discuss your lifestyle habits with your doctor before starting treatment.
Viscum Album Fruiting Top is generally not recommended during pregnancy unless the potential benefits clearly outweigh the risks. There is a lack of comprehensive clinical data regarding its effects on human fetal development, and animal studies have suggested potential risks at high doses. A major concern during pregnancy is the risk of a systemic allergic reaction (anaphylaxis), which can be dangerous for both the mother and the baby. Most clinicians prefer to delay the start of such immunotherapy until after delivery. If you are already on the therapy and become pregnant, your doctor may choose to maintain your current dose but will likely avoid increasing it. Always inform your healthcare provider immediately if you are pregnant or planning to become pregnant.
The time it takes to see results from Viscum Album Fruiting Top depends on the condition being treated and the individual's immune response. For diagnostic allergy testing, the reaction is almost immediate, usually appearing within 15 to 30 minutes. For therapeutic immunomodulation, the process is much slower, often requiring several weeks or even months of regular injections to achieve a steady-state effect on the immune system. Patients may notice an improvement in their general sense of well-being or a stabilization of their condition after 4 to 8 weeks of therapy. Because it works by gradually retraining or stimulating the immune system, consistency is key to its effectiveness. Your doctor will use blood tests and clinical evaluations to monitor your progress over time.
You should not stop taking Viscum Album Fruiting Top suddenly without first consulting your healthcare provider. In the context of desensitization or immunotherapy, stopping the medication abruptly can cause your immune system to lose the tolerance it has built up. If you restart the medication later after a long break, you may be at a much higher risk for a severe allergic reaction. If you need to discontinue the treatment, your doctor will usually provide a schedule to gradually taper the dose or will monitor you closely for any rebound symptoms. Sudden discontinuation is generally not associated with physical withdrawal like narcotics, but it does impact the long-term success of the immunotherapy. Always discuss your reasons for wanting to stop with your medical team.
If you miss a scheduled dose of Viscum Album Fruiting Top, you should contact your doctor's office for instructions. Do not take a double dose to make up for the one you missed, as this could trigger an overactive immune response or a severe local reaction. Depending on how long it has been since your last dose, your doctor may advise you to take the regular dose, or they may need to temporarily reduce the dose to ensure your safety. In some immunotherapy protocols, missing multiple doses may require you to restart the escalation phase from a lower concentration. Keeping a consistent schedule is vital for the safety and efficacy of this treatment. Mark your calendar or set reminders to help you stay on track with your injections.
Weight gain is not a commonly reported side effect of Viscum Album Fruiting Top. Unlike corticosteroids or certain hormonal treatments, Viscum Album does not typically interfere with metabolic rate or appetite in a way that leads to significant weight changes. Some patients may experience mild fluid retention or localized swelling at the injection site, but this is not the same as systemic weight gain. If you notice rapid or unusual weight gain while taking this medication, it may be related to another underlying condition or a different medication you are taking. You should discuss any significant changes in your weight with your healthcare provider to determine the cause. Maintaining a healthy diet and exercise routine is always recommended during any long-term medical therapy.
Viscum Album Fruiting Top can interact with several other types of medications, so a full review of your current prescriptions is necessary. It should be used with caution alongside blood pressure medications, thyroid hormones, and any drugs that affect the immune system, such as steroids or immunosuppressants. One of the most critical interactions is with non-selective beta-blockers, which can make it difficult to treat an allergic reaction if one occurs. Always provide your doctor with a complete list of all medications, including over-the-counter drugs, vitamins, and herbal supplements like St. John's Wort. Your doctor may need to adjust the timing or dosage of your other medications to ensure they do not interfere with the Viscum Album therapy. Coordination between your different healthcare providers is essential.
Viscum Album Fruiting Top is a complex biological extract rather than a simple chemical drug, which means the concept of a 'generic' is slightly different. While there are various brands and manufacturers of European Mistletoe extracts (such as Iscador, Helixor, and Abnoba), they are not necessarily interchangeable. Each manufacturer uses different host trees (like apple, oak, or pine) and different extraction methods, which results in varying concentrations of lectins and viscotoxins. Therefore, a product from one company is considered a 'biosimilar' or a distinct preparation rather than a generic equivalent of another. You should always stay with the specific brand and preparation prescribed by your doctor to ensure consistent dosing and results. Switching brands should only be done under direct medical supervision.
Other drugs with the same active ingredient (Viscum Album Fruiting Top)